Tredaptive

Land: Neuseeland

Sprache: Englisch

Quelle: Medsafe (Medicines Safety Authority)

Wirkstoff:

Laropiprant 20mg;  ; Nicotinic acid 1000mg

Verfügbar ab:

Merck Sharp & Dohme (New Zealand) Limited

INN (Internationale Bezeichnung):

Laropiprant 20 mg

Darreichungsform:

Tablet

Zusammensetzung:

Active: Laropiprant 20mg   Nicotinic acid 1000mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Hyprolose Hypromellose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Sodium stearyl fumarate

Einheiten im Paket:

Blister pack, Al/Al - 7 tablets, 7 tablets

Klasse:

Prescription

Verschreibungstyp:

Prescription

Hergestellt von:

F.I.S. Fabbrica Italiana Sintetici SpA

Produktbesonderheiten:

Package - Contents - Shelf Life: Blister pack, Al/Al - 7 tablets - 7 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 14 tablets - 14 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 28 tablets - 28 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 56 tablets - 56 tablets - 24 months from date of manufacture stored at or below 30°C

Berechtigungsdatum:

2007-08-29